Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Comprehensive Loss

v3.2.0.727
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Revenues    
Product $ 9,939 $ 7,210
Product licensing fees and royalties 3,056 5,513
Service 859 945
Total revenues 13,854 13,668
Cost of revenues    
Product 5,908 4,510
Service 658 761
Total cost of revenues 6,566 5,271
Gross profit 7,288 8,397
Operating expenses    
Research and development 1,533 2,887
Selling, general and administrative 12,414 11,561
Total operating expenses 13,947 14,448
Loss from operations (6,659) (6,051)
Interest expense (3) (1,058)
Interest income 1 1
Gain due to change in fair value of common stock (See Note 10) 0 1,357
Gain on deconsolidation of Ruthigen 0 11,133
Gain (loss) due to change in fair value of derivative instruments 3,164 (1,566)
Impairment loss on long-term investment (See Note 3) (4,650) 0
Other expense, net (56) (81)
Net (loss) income $ (8,203) $ 3,735
(Loss) per common share: Basic $ (0.85) $ 0.54
(Loss) per common share: Diluted $ (0.85) $ 0.54
Weighted-average number of common shares outstanding: Basic 9,657,000 6,882,000
Weighted-average number of common shares outstanding: Diluted 9,657,000 6,898,000
Other comprehensive income (loss)    
Net (loss) income $ (8,203) $ 3,735
Foreign currency translation adjustments (438) (78)
Comprehensive (loss) income $ (8,641) $ 3,657